mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.0006 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0007 |